This is invendo medical

invendo medical aims to become a globally leading developer and distributor of disposable, highly flexible and easy-to-use endoscopy products in the field of gastroenterology.

Innovation activity in gastroenterological endoscopy has in the past decades nearly exclusively focused on the improvement of optical capabilities. However, invendo medical´s goal is to improve patient compliance and thereby increase the number of procedures performed.

In order to achieve its goal the company first focussed on an application in the diagnosis and treatment of colorectal cancers (CRC). CRC is the second leading cause of cancer death with an estimated annual worldwide death toll of 510,000 people. More than 1 million new cases are diagnosed every year. However 90-100% of colorectal cancers can be avoided if diagnosed early on.

Current screening options for CRC include fecal occult blood test (FOBT), flexible sigmoidoscopy, the combination of FOBT and flexible sigmoidoscopy, and colonoscopy. Colonoscopy is the undisputed gold standard for colorectal screening because it provides very high sensitivity (> 90%) with a false negative rate of 6% for adenomas 1 cm or more in diameter.

Nevertheless colonoscopy as a screening method is underused due to patient concerns about:

  • associated pain (mainly due to looping caused by the semi-rigidity of conventional colonoscopes).
  • potential cross-infection risks (due to the inability to sterilize conventional colonoscopes; intensive cleaning processes are required).
  • potential complications related to sedation, which is frequently applied.

In addition, in many countries endoscopic capacity cannot currently satisfy the growing demand for colonoscopies, because conventional colonoscopy is not an easily learned technique and requires extensive training prior to routinely performing the procedure.

Therefore invendo medical is addressing these issues by developing a new "no-touch/no-push" technology in combination with a highly flexible, single-use endoscope which aims to improve colonoscopy so that:

  • patients experience a well-tolerable procedure;
  • possible cross-infection risks are significantly reduced;
  • it is easily learned and more ergonomical than conventional practice;
  • work processes can be efficiently organised.

It is invendo's goal to continue to develop this innovative, highly flexible single-use endoscopy technology into a complete product portfolio and establish it in the market.

 

 

News

invendo medical announces 510(k) clearance by FDA

Clearance by FDA makes new endoscope for colon cancer screening available to U.S. patients More

Paper on clinical study with invendoscopy system published in the American Journal of Gastroenterology

invendo medical announced that a scientific paper about the successfully completed pivotal study for US clearance with t... More

» More news ...